English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 10 September 2014, 12:50 HKT/SGT
Share:
Tianhe Chemicals, backed by MSPEA, Prepares to Fight back Short Sellers

HONG KONG, Sept 10, 2014 - (ACN Newswire) - Tianhe Chemicals (Stock Code: 1619.HK) is preparing a full rebuttal against attacks from Anonymous Analytics, a short selling organization, in the form of a clarification announcement, as people familiar with the matter said. Shares will remain suspended until the formal clarification is published.

According to Wall Street Journal, Tianhe Chemicals CEO Wei Xuan acted fast after the AA report was published. In Boston at the time, Mr. Wei asked the Hong Kong stock exchange to suspend trading in the company's shares. A brief statement was swiftly announced by the company to the Hong Kong stock exchange saying the allegations were inaccurate, followed by the one on last Friday calling Anonymous' charges "false, misleading and malicious."

According to Reuters, Morgan Stanley Private Equity Asia (MSPEA) is the largest institutional investor in Tianhe Chemicals, with 8.6 percent of the company's stock, and the bank also has 27 percent of the MSPEA fund which invested in Tianhe Chemicals. Before MSPEA's $300 million investment in Tianhe Chemicals in 2012, it spent over $2 million on third-party diligence work over a three-year period. Such in-depth diligence check would usually involve deep reviews on the company's financials, its production facilities and its customer base.

Anonymous Analytics, on the other hand, says it conducted all of its investigations using public information, in addition to a few visits to the offices of Tianhe customers in Shanghai.

Reuters also points out that while Anonymous has a patchy record of success with its reports, Morgan Stanley's unit has never made a loss on a China investment in over 20 years of deals, a record that is the envy of peers who have suffered reputational and financial damage from claims of fraud at their China portfolio companies. In addition, MSPEA actively promoted the Tianhe Chemicals investment when it was raising its fourth and biggest Asia fund of $1.7 billion.

Homer Sun, MSPEA's chief investment officer and head of its China investments team, sits on the Tianhe Chemicals board as a non-executive director, along with specialists whose background includes stints at Dupont, Conoco and Standard Oil.


Topic: Press release summary Sectors: Daily Finance, Daily News
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
UK advertising reports GBP36.6bn spend in 2023  
Apr 26, 2024 17:30 HKT/SGT
CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine  
Apr 26, 2024 15:36 HKT/SGT
Edvantage Group Announces FY2024 Interim Results  
Apr 26, 2024 13:43 HKT/SGT
Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project  
Apr 26, 2024 13:27 HKT/SGT
Imexpharm Corporation Hosts Shareholders, Analysts and Potential Investors at its 2024 Annual General Meeting  
Apr 26, 2024 13:16 HKT/SGT
JCB enables JCB Contactless acceptance at Taichung MRT in Taiwan  
Friday, April 26, 2024 9:00:00 AM
Jeff Martin Auctioneers to Manage Sale of Sabine Mining Company Assets for North American Coal  
Apr 26, 2024 08:00 HKT/SGT
Cambridge Isotope Laboratories (CIL) Shows Long-Term Commitment to Xenia, Ohio, Facility With New Land Purchase  
Apr 25, 2024 21:00 HKT/SGT
Black Spade Donates Art and Jewellery Collection To Hong Kong Red Cross  
Apr 25, 2024 20:40 HKT/SGT
Q2 Metals Announces Assay Results from Its 2023 Inaugural Drill Program at the Mia Lithium Property, James Bay Territory, Quebec, Canada  
Apr 25, 2024 19:09 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575